MedPath

Nulliparous Women and Education and Counseling

Not Applicable
Completed
Conditions
Pregnancy
Interventions
Behavioral: Education and counseling
Registration Number
NCT05214846
Lead Sponsor
Ondokuz Mayıs University
Brief Summary

This study investigates the effect of education and counseling on anxiety and depression in nullipar women.

Detailed Description

Pregnancy is a special process in a woman's life in which physiological, social and psychological changes occur. In this process, most women experience anxiety and depression, which are an important global health problem.The fear of uncertainty experienced by women who will become mothers for the first time may cause them to experience more anxiety/depression. The aim of this study was to investigate the effect of education and counseling on anxiety and depression of women.

This randomized controlled study was conducted at state hospital in northern Turkey , Obstetrics and Gynecology polyclinic between January 2022 and March 2022. Volunteer women undergoing polyclinic have been included. Participants were randomly assigned to the intervention or the control group using a computer-generated list. A data collection form including socio-demographic and obstetric characteristics such as age, educational status, Hospital Anxiety Depression Scale (HADS) was used for each patient. After obtaining written informed consent, the data collection form, Hospital Anxiety Depression Scale (HADS) were applied to both groups by face to face interview. Immediately after the questionnaires were applied, the nurse gave individual education and counseling were giving by the nurse researcher to intervention group for 30 minutes. Participants in the control group received standard care (verbal information about procedure and a short written information about the procedure) and no intervention (education and counseling) was performed.The IBM SPSS (Statistical package for the Social Sciences) 23.0 package program was used to evaluate the data obtained in the study.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • A healthy pregnant woman over 18 years of age,
  • without a diagnosed psychiatric disease,
  • without mental disability and communication problems,
  • at 28 weeks of gestation,
  • nulliparous,
  • without fetal anomaly,
  • without risky pregnancy
Exclusion Criteria
  • A healthy pregnant woman under 18 years of age,
  • with a diagnosed psychiatric disease,
  • with mental disability and communication problems,
  • under 28 weeks of gestation,
  • multiparous,
  • with fetal anomaly,
  • with risky pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Education and CounselingEducation and counselingAfter obtaining written informed consent, the data collection form, Hospital Anxiety Depression Scale (HADS) was applied to both groups by face to face interview. Immediately after the questionnaires were applied, the nurse gave individual education and counseling were giving by the nurse researcher to intervention group for 30 minutes. Women were counseled for 6 weeks. Anxiety-depression levels (post-test) were applied by phone call 6 weeks later.This education consisted of the definition and the purpose of pregnancy and pregnancy problems and nutrition during pregnancy, sexuality during pregnancy, number of fetal movements, preparation of the delivery bag, breast care, etc.
Primary Outcome Measures
NameTimeMethod
Hospital Anxiety Depression Scale (HADS)30 minutes

The HADS contains 14 items and consists of two subscales: anxiety and depression. Each item is rated on a four-point scale, giving maximum scores of 21 for anxiety and depression. Scores of 11 or more on either subscale are considered to be a significant 'case' of psychological morbidity, while scores of 8-10 represents 'borderline' and 0-7 'normal' (Zigmont ve Snaith).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ondokuz Mayis University

🇹🇷

Samsun, Atakum, Turkey

© Copyright 2025. All Rights Reserved by MedPath